A bold, new initiative made possible by a generous $5 million gift from Weill Cornell Medicine
Overseer Igor Tulchinsky will enhance the diagnosis and treatment of a variety of illnesses,
including cancer, infectious diseases, and a range of neurological disorders.
Tulchinsky’s gift, made through his company, WorldQuant, LLC, has established the
WorldQuant Initiative for Quantitative Prediction at Weill Cornell Medicine, a biomedical
research initiative that will function in collaboration with scientists and physician investigators
at the Caryl and Israel Englander Institute for Precision Medicine and the Sandra and Edward
Meyer Cancer Center.
The initiative aims to expand current strategies used in precision medicine by combining
state-of-the-art molecular profiling technologies with advanced financial algorithms and
computational methods, creating personalized disease and health models that will optimize
treatment for patients.